Respiratory Virus

Value-Based Messaging Increases Vaccine Openness by Up to 16 Percentage Points

Ken Ishii’s University of Tokyo researchers develop nasal immune adjuvant providing months-Long protection against respiratory viruses

by

University of Tokyo Researchers Develop Nasal Immune Adjuvant Protecting Mice Against Respiratory Viruses A nanosized nasal immune adjuvant designated K3-SPG protects mice against respiratory viral infections for months, according to … Read More